Status:
COMPLETED
Population Pharmacokinetics of Ropivacaine
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study was to investigate the pharmacokinetics of free and total ropivacaine after unilateral and bilateral TKA. A population model was successfully built and peak free ropivacaine conc...
Detailed Description
Thirteen unilateral TKA and fifteen bilateral TKA patients were included in the study. All patients were operated in a well-described fast-track setup without use of drains or tourniquet.21 A standard...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients undergoing unilateral TKA (n=13) and bilateral TKA (n=15) receiving LIA according to standard protocol.
- Exclusion criteria:
- Patients not receiving LIA Revision TKA
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04702282
Start Date
January 1 2017
End Date
September 30 2019
Last Update
January 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.